Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DPCM Capital, Inc.XPOA · Entity 124742 | Director | August 05, 2022 | August 09, 2022 |
| SkinHealth Systems Inc.SKIN · Entity 6863 | Director | June 16, 2025 | June 18, 2025 |
| Slam Corp.SLAM · Entity 54573 | Director | February 22, 2021 | February 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DPCM Capital, Inc.
Report date August 05, 2022 · Filed August 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-08-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-08-05 · Conversion · Acquired 37,500 · Balance 37,500 F1: As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading "Description of Securities," the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer ("Class A Common Stock") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date. F2: (Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the "Business Combination") with D-Wave Quantum, Inc. ("Newco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock. Row 2 · 2022-08-05 · Other · Disposed 37,500 · Balance 0 F3: In connection with the Business Combination, the Reporting Person exchanged its shares of Class A Common Stock for 37,500 fully paid and non-assessable shares of common stock, par value U.S. $0.0001 per share of Newco. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-08-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-08-05 · Conversion · Disposed 37,500 · Balance 0 F1: As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading "Description of Securities," the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer ("Class A Common Stock") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date. F2: (Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the "Business Combination") with D-Wave Quantum, Inc. ("Newco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading "Description of Securities," the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer ("Class A Common Stock") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date.
F2: (Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the "Business Combination") with D-Wave Quantum, Inc. ("Newco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock.
F3: In connection with the Business Combination, the Reporting Person exchanged its shares of Class A Common Stock for 37,500 fully paid and non-assessable shares of common stock, par value U.S. $0.0001 per share of Newco.
SkinHealth Systems Inc.
Report date June 16, 2025 · Filed June 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 192,565 |
Reported balance
After 2025-06-16 transaction · row 1
1 source rowRow 1 · 2025-06-16 · Grant · Acquired 73,051 · Balance 192,565 F1: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time.
Slam Corp.
Report date February 22, 2021 · Filed February 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B ordinary sharesSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-02-22 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252727) under the heading "Description of Securities-Founder Shares", the Class B ordinary shares, par value $0.0001, will automatically convert into Class A ordinary shares, par value $0.0001, of the issuer at the time of the issuer's initial business combination transaction on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252727) under the heading "Description of Securities-Founder Shares", the Class B ordinary shares, par value $0.0001, will automatically convert into Class A ordinary shares, par value $0.0001, of the issuer at the time of the issuer's initial business combination transaction on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2025 Filed Jun 18, 2025 20:34 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 73,051 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-032142 · wk-form4_1750278883.xml · nonDerivative · entry 1 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,565 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 21:48 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | SaleClass A Common Stock | 14,663 | $1.50 | $22,022.36 |
DisclosureSEC source: 0001628280-24-048855 · wk-form4_1732225709.xml · nonDerivative · entry 1 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,514 Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 20:52 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 78,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-031610 · wk-form4_1720644723.xml · nonDerivative · entry 1 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,177 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:17 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 16,357 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-022511 · wk-form4_1686950243.xml · nonDerivative · entry 1 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,643 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:30 UTC | DPCM Capital, Inc. XPOA · Entity 124742 | ConversionClass B Common Stock · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-028095 · doc4.xml · derivative · entry 3 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading "Description of Securities," the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer ("Class A Common Stock") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date. F2 · derivative.exercise_price: (Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the "Business Combination") with D-Wave Quantum, Inc. ("Newco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock. F1 · derivative.exercise_date: As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading "Description of Securities," the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer ("Class A Common Stock") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date. F2 · derivative.exercise_date: (Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the "Business Combination") with D-Wave Quantum, Inc. ("Newco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock. F1 · derivative.expiration_date: As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading "Description of Securities," the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer ("Class A Common Stock") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date. F2 · derivative.expiration_date: (Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the "Business Combination") with D-Wave Quantum, Inc. ("Newco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:30 UTC | DPCM Capital, Inc. XPOA · Entity 124742 | OtherClass A Common Stock | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-028095 · doc4.xml · nonDerivative · entry 2 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: In connection with the Business Combination, the Reporting Person exchanged its shares of Class A Common Stock for 37,500 fully paid and non-assessable shares of common stock, par value U.S. $0.0001 per share of Newco. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:30 UTC | DPCM Capital, Inc. XPOA · Entity 124742 | ConversionClass A Common Stock | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-028095 · doc4.xml · nonDerivative · entry 1 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As describd in the DPCM Capital, Inc.'s registration statement on Form S-1 (File No. 333-249274) under the heading "Description of Securities," the Class B Common Stock of the issuer automatically converts into Class A Common Stock of the issuer ("Class A Common Stock") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date. F2 · price: (Continued from Footnote 1) On August 5, 2022, the issuer consummated its initial business combination (the "Business Combination") with D-Wave Quantum, Inc. ("Newco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock. Read SEC document |
| June 28, 2022 Filed Jul 1, 2022 00:08 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 9,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001818093-22-000123 · wf-form4_165663410884797.xml · nonDerivative · entry 1 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,286 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 01:24 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 4,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000077 · wf-form4_163166903913360.xml · nonDerivative · entry 1 Gruber Desiree · CIK 0001828069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,353 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the date of the 2022 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the date of the 2022 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.